An Act to reduce the risks associated with allergic reactions

HD 2506, "An Act to reduce the risks associated with allergic reactions," allows businesses (like restaurants, schools, or stores) to keep epinephrine auto-injectors available for immediate use during severe allergic reactions. It permits employees who complete required training to administer the auto-injector to anyone showing signs of anaphylaxis, even without a prescription or prior diagnosis, and provides liability protection for good-faith actions (excluding gross negligence). The bill mandates incident reporting for severe allergic reactions or auto-injector use, requires standardized training for staff covering symptom recognition and administration, and establishes annual public reporting on these incidents. Businesses that comply may also earn certification as "allergy-friendly" environments.